Related Experiment Video
Updated: Jan 17, 2026

08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.6K
Brief pain reprocessing therapy for fibromyalgia: a feasibility, acceptability, and preliminary efficacy pilot
John Sturgeon1, Zina Trost2, Yoni K Ashar3
1Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan, USA jsturgeo@med.umich.edu.
Regional Anesthesia and Pain Medicine
|September 19, 2025
Summary
Brief Pain Reprocessing Therapy (BPRT) is a feasible and acceptable telehealth intervention for fibromyalgia, significantly reducing pain, interference, and fear. This novel approach shows promise for managing nociplastic pain conditions.
Area of Science:
- Pain Medicine
- Behavioral Psychology
- Telehealth Interventions
Background:
- Fibromyalgia (FM) is a prevalent, disabling condition characterized by nociplastic pain.
- Current treatments offer limited efficacy due to potential mechanism mismatches.
- A novel behavioral intervention targeting nociplastic pain mechanisms is needed.
Purpose of the Study:
- To examine the feasibility and acceptability of Brief Pain Reprocessing Therapy (BPRT) for fibromyalgia.
- To assess the preliminary efficacy of a three-session telehealth BPRT intervention.
- To evaluate BPRT's impact on pain intensity, interference, and fear in FM patients.
Main Methods:
- A single-arm, open-label trial involving 35 adults with FM.
- Participants received three one-on-one telehealth BPRT sessions.
- Online questionnaires assessed pain outcomes pre-intervention and at 1, 2, and 3 months post-intervention.
Main Results:
- High completion rate (94.3%) and acceptability of BPRT.
- Significant reductions in average pain intensity, pain interference, and pain-related fear.
- Substantial improvements reported by 42.3% of completers at 3-month follow-up.
Conclusions:
- Brief Pain Reprocessing Therapy (BPRT) is a feasible and acceptable telehealth intervention for FM.
- Preliminary efficacy suggests BPRT can reduce pain, interference, and fear.
- Larger trials are warranted to confirm efficacy and explore mechanisms.

